Octreoscan

Octreoscan

Octreoscan is a scintigraphic method based on 111Indium-DOTA-Octreotide which is binding to tumors expressing somatostatin receptor type 2 and 5. Since 80-90% of neuroendocrine tumors are expressing these receptors it is a very important diagnostic and staging investigation.